Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile
Cancer Center @ CHOP

@chopcancercntr

The Cancer Center @ChildrensPhila offers children from all over the world, compassionate care combined with the latest treatment options for #pediatriccancer.

ID: 270376038

linkhttp://cancer.chop.edu calendar_today22-03-2011 14:13:37

1,1K Tweet

3,3K Followers

1,1K Following

CHOP Research (@chop_research) 's Twitter Profile Photo

A pioneering #cancer treatment for solid high-risk tumors in development with Children's Hospital researchers could overcome the disadvantages of traditional chemotherapy. Learn more about PEEL-224: ms.spr.ly/6014qavhK Cancer Center @ CHOP

A pioneering #cancer treatment for solid high-risk tumors in development with <a href="/ChildrensPhila/">Children's Hospital</a> researchers could overcome the disadvantages of traditional chemotherapy. Learn more about PEEL-224: ms.spr.ly/6014qavhK
<a href="/CHOPCancerCntr/">Cancer Center @ CHOP</a>
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

CHOP researchers generated and evaluated the largest human dataset currently available comparing BWS and non-BWS pediatric livers, shedding light on how this rare pediatric overgrowth syndrome may raise cancer risk. Learn more: ms.spr.ly/6019qFJFD.

CHOP researchers generated and evaluated the largest human dataset currently available comparing BWS and non-BWS pediatric livers, shedding light on how this rare pediatric overgrowth syndrome may raise cancer risk. Learn more: ms.spr.ly/6019qFJFD.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

CHOP researchers develop cell atlas of neuroblastoma to understand why and how certain treatments eventually become ineffective. The study offer insights that could potentially lead to new personalized medicine approaches. Learn more about the findings: ms.spr.ly/6013q7QdT.

CHOP researchers develop cell atlas of neuroblastoma to understand why and how certain treatments eventually become ineffective. The study offer insights that could potentially lead to new personalized medicine approaches. 

Learn more about the findings: ms.spr.ly/6013q7QdT.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Join us for our BWSp Symposium on July 18-20 at our Philly campus. This event will provide the most recent updates on diagnostic and clinical management information, as well as the latest research findings related to the condition. Learn more & register: ms.spr.ly/6010S1ISj.

Join us for our BWSp Symposium on July 18-20 at our Philly campus. This event will provide the most recent updates on diagnostic and clinical management information, as well as the latest research findings related to the condition.

Learn more &amp; register: ms.spr.ly/6010S1ISj.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

At #CelliconValley25: our cell therapy experts discuss topics on gene therapies for inherited bone marrow failure syndromes, immune-related adverse events of CAR-T, and cell therapies to treat autoimmunity in peds patients.

At #CelliconValley25: our cell therapy experts discuss topics on gene therapies for inherited bone marrow failure syndromes, immune-related adverse events of CAR-T, and cell therapies to treat autoimmunity in peds patients.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Members of our team lead a #CelliconValley25 panel discussion this afternoon on what happens behind the scenes to navigate coverage policies and prior authorizations for cell and gene therapies. Penn Medicine

Members of our team lead a #CelliconValley25 panel discussion this afternoon on what happens behind the scenes to navigate coverage policies and prior authorizations for cell and gene therapies. <a href="/PennMedicine/">Penn Medicine</a>
CHOP Advocacy (@chopadvocacy) 's Twitter Profile Photo

Check out CHOP Researcher, Aime Franco, PhD, who testified on behalf of a bill in NJ that recently became law! Learn more about precision medicine and how it changes how we approach cancer treatment 🔬 Cancer Center @ CHOP aime franco Aime Franco northjersey.com/story/news/hea…

Check out CHOP Researcher, Aime Franco, PhD, who testified on behalf of a bill in NJ that recently became law! Learn more about precision medicine and how it changes how we approach cancer treatment 🔬
<a href="/CHOPCancerCntr/">Cancer Center @ CHOP</a> <a href="/amos18/">aime franco</a> <a href="/thyroidlab/">Aime Franco</a> 
northjersey.com/story/news/hea…
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

We’re excited to be at #ASPHO2025! Our Drs. Suzanne MacFarland and Jennifer Kalish gave talks during the pediatric cancer predisposition and surveillance session. Attending the conference? Be sure to stop by our booth #218 tomorrow. We’ll be there starting at 3:45 pm!

We’re excited to be at #ASPHO2025! Our Drs. Suzanne MacFarland and Jennifer Kalish gave talks during the pediatric cancer predisposition and surveillance session. Attending the conference? Be sure to stop by our booth #218 tomorrow. We’ll be there starting at 3:45 pm!
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Dr. Charles Phillips, who chaired the ASPHO Informatics, Innovation and Entrepreneurship Special Interest Group, presented on the use of the electronic health record in tracking quality measures at #ASPHO2025.

Dr. Charles Phillips, who chaired the ASPHO Informatics, Innovation and Entrepreneurship Special Interest Group, presented on the use of the electronic health record in tracking quality measures at #ASPHO2025.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Our Dr. Christina Turn presenting her poster titled: “Stimulating Natural Killer Cell Cytotoxicity with Polyamine Synthesis Inhibition and TGFβ Inhibiton” at #ASPHO2025. American Society of Pediatric Hematology/Oncology

Our Dr. Christina Turn presenting her poster titled: “Stimulating Natural Killer Cell Cytotoxicity with Polyamine Synthesis Inhibition and TGFβ Inhibiton” at #ASPHO2025. <a href="/ASPHO_hq/">American Society of Pediatric Hematology/Oncology</a>
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Attending #ASPHO2025? Stop by our booth #218 to say hello to Dr. Jason Freedman and Program Coordinator Zach Harvey to learn about our cutting-edge research and programs, and to pick up some free swag. We have pizza cutters, pens and much more! American Society of Pediatric Hematology/Oncology

Attending #ASPHO2025? Stop by our booth #218 to say hello to Dr. Jason Freedman and Program Coordinator Zach Harvey to learn about our cutting-edge research and programs, and to pick up some free swag. We have pizza cutters, pens and much more! <a href="/ASPHO_hq/">American Society of Pediatric Hematology/Oncology</a>
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Dr. Denise Adams, Director of the Comprehensive Vascular Anomalies Program at CHOP, kicked off one of the educational sessions this morning at #ASPHO2025 with her presentation titled: “Vascular Anomalies Have Found a Home in Pediatric Hematology/Oncology.”

Dr. Denise Adams, Director of the Comprehensive Vascular Anomalies Program at CHOP, kicked off one of the educational sessions this morning at #ASPHO2025 with her presentation titled: “Vascular Anomalies Have Found a Home in Pediatric Hematology/Oncology.”
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

A global team of researchers, led by CHOP's Dr. Yael Mossé, is pioneering a new class of drugs that offer a promising approach to treating some of the most challenging pediatric cancers. Read more in this nature report, below. ms.spr.ly/6010Sn25o

Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Drexel medical student Maanasi Gothoskar collaborated with two of our researchers last summer to study the epidemiology of post-transplant lymphoproliferative disorder. Here she is at #ASPHO2025, representing CHOP and showcasing a poster of her research!

Drexel medical student Maanasi Gothoskar collaborated with two of our researchers last summer to study the epidemiology of post-transplant lymphoproliferative disorder. Here she is at #ASPHO2025, representing CHOP and showcasing a poster of her research!
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

A new study published in Journal of Clinical Oncology features our patient & her mom, who both have hereditary neuroblastoma, demonstrating that ALK inhibition therapy is effective in managing the disease. This research can help establish a new standard of care. More: ms.spr.ly/6011Sk9TS.

A new study published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> features our patient &amp; her mom, who both have hereditary neuroblastoma, demonstrating that ALK inhibition therapy is effective in managing the disease. This research can help establish a new standard of care. 

More: ms.spr.ly/6011Sk9TS.
Cancer Center @ CHOP (@chopcancercntr) 's Twitter Profile Photo

Congratulations to John Simpkins, Chief Administrative Officer of our Cancer Center, on receiving the Alex’s Lemonade Stand Pitcher of Hope Award. This award honors a CHOP employee who has made a significant impact in pediatric oncology. Learn more: ms.spr.ly/6011SqOkN.

Congratulations to John Simpkins, Chief Administrative Officer of our Cancer Center, on receiving the Alex’s Lemonade Stand Pitcher of Hope Award. This award honors a CHOP employee who has made a significant impact in pediatric oncology. 

Learn more: ms.spr.ly/6011SqOkN.
CGTLive® (@cgt_live) 's Twitter Profile Photo

ICYMI: In this episode of #ImmunoLogic, the cohosts speak with Caroline Diorio, MD, an attending physician at the Cancer Center at Children's Hospital, about her research into inflammatory toxicities in #celltherapy. #CART #immunotherapy Listen now: hubs.li/Q03rMGqZ0

ICYMI:

In this episode of #ImmunoLogic, the cohosts speak with Caroline Diorio, MD, an attending physician at the Cancer Center at <a href="/ChildrensPhila/">Children's Hospital</a>, about her research into inflammatory toxicities in #celltherapy.

#CART #immunotherapy

Listen now:

hubs.li/Q03rMGqZ0
Children's Hospital (@childrensphila) 's Twitter Profile Photo

Delivering serious news is never easy, but can be learned. In this episode of the Primary Care Perspectives podcast, Dr. Julie Stern, Director of Outreach Services at Cancer Center @ CHOP, shares insights on navigating tough conversations with patient families. ms.spr.ly/6017SAKht